Paper35112802
Nano-in-Microparticles for Aerosol Delivery of Antibiotic-Loaded, Fucose-Derivatized, and Macrophage-Targeted Liposomes to Combat Mycobacterial Infections: In Vitro Deposition, Pulmonary Barrier Interactions, and Targeted Delivery.
Huck BC and 19 others. Adv Healthc Mater, 2022. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Nano-in-Microparticles for Aerosol Delivery of Antibiotic-Loaded, Fucose-Derivatized, and Macrophage-Targeted Liposomes to Combat Mycobacterial Infections: In Vitro Deposition, Pulmonary Barrier Interactions, and Targeted Delivery. Papers, record 35112802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35112802
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Nano-in-Microparticles for Aerosol Delivery of Antibiotic-Loaded, Fucose-Derivatized, and Macrophage-Targeted Liposomes to Combat Mycobacterial Infections: In Vitro Deposition, Pulmonary Barrier Interactions, and Targeted Delivery.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Liposomes | Major topic |
| Administration, Inhalation | |
| Aerosols | |
| Dry Powder Inhalers | |
| Fucose | |
| Lung | |
| Macrophages | |
| Particle Size | |
| Powders |
Source PubMed
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25629008 | Manipulation of the endocytic pathway and phagocyte functions by Mycobacterium tuberculosis lipoarabinomannan. | Front Cell Infect Microbiol | 2014 | https://conductscience.org/library/papers/25629008 | PubMed |
| 2 | 7594549 | Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. | J Immunol | 1995 | https://conductscience.org/library/papers/7594549 | PubMed |
| 3 | 9609735 | Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. | Am J Physiol | 1998 | https://conductscience.org/library/papers/9609735 | PubMed |
| 4 | 19236209 | Recent advances in liposomal dry powder formulations: preparation and evaluation. | Expert Opin Drug Deliv | 2009 | https://conductscience.org/library/papers/19236209 | PubMed |
| 5 | 14568408 | Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection. | J Control Release | 2003 | https://conductscience.org/library/papers/14568408 | PubMed |
| 6 | 25940082 | In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory Approaches. | AAPS J | 2015 | https://conductscience.org/library/papers/25940082 | PubMed |
| 7 | 21512579 | Targeted liposomal drug delivery to monocytes and macrophages. | J Drug Deliv | 2011 | https://conductscience.org/library/papers/21512579 | PubMed |
| 8 | 29626567 | Evaluation of the intracellular activity of drugs against Mycobacterium abscessus using a THP-1 macrophage model. | J Microbiol Methods | 2018 | https://conductscience.org/library/papers/29626567 | PubMed |
| 9 | 16382966 | Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. | Environ Sci Technol | 2005 | https://conductscience.org/library/papers/16382966 | PubMed |
| 10 | 35112802 | Nano-in-Microparticles for Aerosol Delivery of Antibiotic-Loaded, Fucose-Derivatized, and Macrophage-Targeted Liposomes to Combat Mycobacterial Infections: In Vitro Deposition, Pulmonary Barrier Interactions, and Targeted Delivery. | Adv Healthc Mater | 2022 | https://conductscience.org/library/papers/35112802 | PubMed |
| 11 | 33865899 | Fucosylated lipid nanocarriers loaded with antibiotics efficiently inhibit mycobacterial propagation in human myeloid cells. | J Control Release | 2021 | https://conductscience.org/library/papers/33865899 | PubMed |
| 12 | 29534242 | Air-Liquid Interface: Relevant In Vitro Models for Investigating Air Pollutant-Induced Pulmonary Toxicity. | Toxicol Sci | 2018 | https://conductscience.org/library/papers/29534242 | PubMed |
| 13 | 23583840 | Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats. | Int J Pharm | 2013 | https://conductscience.org/library/papers/23583840 | PubMed |
| 14 | 23262166 | Correlation of drug release with pulmonary drug absorption profiles for nebulizable liposomal formulations. | Eur J Pharm Biopharm | 2013 | https://conductscience.org/library/papers/23262166 | PubMed |
| 15 | 22290346 | Mycobacterium abscessus: a new antibiotic nightmare. | J Antimicrob Chemother | 2012 | https://conductscience.org/library/papers/22290346 | PubMed |
| 16 | 28290290 | Mucus interactions with liposomes encapsulating bioactives: Interfacial tensiometry and cellular uptake on Caco-2 and cocultures of Caco-2/HT29-MTX. | Food Res Int | 2017 | https://conductscience.org/library/papers/28290290 | PubMed |
| 17 | 28373109 | Modelling the bronchial barrier in pulmonary drug delivery: A human bronchial epithelial cell line supplemented with human tracheal mucus. | Eur J Pharm Biopharm | 2017 | https://conductscience.org/library/papers/28373109 | PubMed |
| 18 | 29867826 | Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages. | Front Microbiol | 2018 | https://conductscience.org/library/papers/29867826 | PubMed |
| 19 | 34101127 | Spray-dried lactose-leucine microparticles for pulmonary delivery of antimycobacterial nanopharmaceuticals. | Drug Deliv Transl Res | 2021 | https://conductscience.org/library/papers/34101127 | PubMed |
| 20 | 32781595 | General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens: Mycobacterium avium and Mycobacterium abscessus. | J Clin Med | 2020 | https://conductscience.org/library/papers/32781595 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42130023 | One-Step Microfluidic Manufactured Fucose-Decorated Sweetosomes Choose the Time and the Road for Their Intracellular Journey to Cancer Treatment. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/42130023 | PubMed |
| 42032391 | Bioactive co-assembly of PSA/diT-VES nanomicelles orchestrates macrophage reprogramming for acute lung injury therapy. | Drug Deliv Transl Res | 2026 | https://conductscience.org/library/papers/42032391 | PubMed |
| 41969646 | Inhaled formulations for bacterial pneumonia: Strategies and advances in drug delivery. | Bioact Mater | 2026 | https://conductscience.org/library/papers/41969646 | PubMed |
| 40724029 | Liposome-Encapsulated Antibiotics for the Therapy of Mycobacterial Infections. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/40724029 | PubMed |
| 40478382 | Bisphosphonates loaded nanoparticles in microparticles: a potential macrophage targeting and repolarizing drug delivery system. | Drug Deliv Transl Res | 2026 | https://conductscience.org/library/papers/40478382 | PubMed |
| 40124344 | Treatment of lung diseases via nanoparticles and nanorobots: Are these viable alternatives to overcome current treatments? | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40124344 | PubMed |
| 39141300 | Spray Drying of Bacterial Membrane Vesicles for Vaccine Delivery. | Methods Mol Biol | 2024 | https://conductscience.org/library/papers/39141300 | PubMed |
| 39136125 | Intranasal Administration of Bedaquiline-Loaded Fucosylated Liposomes Provides Anti-Tubercular Activity while Reducing the Potential for Systemic Side Effects. | ACS Infect Dis | 2024 | https://conductscience.org/library/papers/39136125 | PubMed |
| 38577780 | Targeting Intracellular Bacteria with Dual Drug-loaded Lactoferrin Nanoparticles. | ACS Infect Dis | 2024 | https://conductscience.org/library/papers/38577780 | PubMed |
| 38543241 | State-of-the-Art Review on Inhalable Lipid and Polymer Nanocarriers: Design and Development Perspectives. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38543241 | PubMed |
| 38384321 | Opportunities and Challenges for Inhalable Nanomedicine Formulations in Respiratory Diseases: A Review. | Int J Nanomedicine | 2024 | https://conductscience.org/library/papers/38384321 | PubMed |
| 38341386 | Antibiotic resistance and tolerance: What can drug delivery do against this global threat? | Drug Deliv Transl Res | 2024 | https://conductscience.org/library/papers/38341386 | PubMed |
| 36839715 | Nanosized Drug Delivery Systems to Fight Tuberculosis. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36839715 | PubMed |
| 35112802 | Nano-in-Microparticles for Aerosol Delivery of Antibiotic-Loaded, Fucose-Derivatized, and Macrophage-Targeted Liposomes to Combat Mycobacterial Infections: In Vitro Deposition, Pulmonary Barrier Interactions, and Targeted Delivery. | Adv Healthc Mater | 2022 | https://conductscience.org/library/papers/35112802 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35112802
GET https://conductscience.org/api/papers/v1/35112802/references?page=2